Literature DB >> 18221283

Does erectile tissue angioarchitecture modify with aging? An immunohistological and morphometric approach.

Carla Costa1, Pedro Vendeira2.   

Abstract

Introduction. Erectile dysfunction is a common problem in aged men; however, which vascular cavernosal alterations occur with age progression remain unclarified. Aim. Using cavernosal tissue from rats of various ages, we aimed to thoroughly assess erectile vascular-associated morphologic, immunohistological, and morphometric alterations during aging. Methods. Male Wistar rats were divided according to age in groups of 2, 6, 12, 18, 24 months old (N = 5). Cavernosal tissue of all groups was collected and processed for morphologic evaluation, immunodetection of alpha-smooth muscle actin and von Willebrand factor and morphometric quantification of vascular and smooth muscle cell (SMC) areas. Main Outcome Measures. The morphometric assessment of age-related alterations in cavernosal vascular and SMCs using the ImageJ image-processing program. Results. Morphologic and immunohistological evaluation showed a similar structure of erectile tissue among all age groups, divided in two cavernosal bodies containing numerous sinusoidal vascular spaces surrounded by SMCs. Additionally, we observed a reduction of SMC content and an increase in the caliber of vascular spaces, with aging. This was confirmed by the morphometric quantification of the vascular and SMC areas (mean area x10(3) microm(2) +/- x10(3) standard error). Two-month-old animals had a mean vascular area of 4.21 +/- 0.51, approximately 3.5-fold less than the 6-month-old group. The differences increased when comparing the youngest groups with the 12-, 18-, and 24-month-old animals, with mean measurements of 18.99 +/- 1.91, 25.23 +/- 2.76, and 26.34 +/- 2.97. Conversely, SMC areas progressively decreased between 2- and 6-month-old animals, from 6.75 +/- 0.90 to 6.38 +/- 1.24. The elderly 12-, 18-, and 24-month-old groups presented an approximated 1.5-fold reduction on SMCs area, showed by the respective measurements of 4.11 +/- 0.50, 4.01 +/- 0.35, and 4.02 +/- 0.44. Conclusions. We demonstrated that cavernosal angioarchitecture was modified with aging. The decrease in SMCs and the considerable enlargement of vascular lumens may limit the basic function of penile vascular tree in the elderly.

Entities:  

Mesh:

Year:  2008        PMID: 18221283     DOI: 10.1111/j.1743-6109.2007.00753.x

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  5 in total

1.  Erectile tissue molecular alterations with aging: differential activation of the p42/44 MAP Kinase pathway.

Authors:  Angela Castela; Raquel Soares; Fátima Rocha; Pedro Vendeira; Ronald Virag; Carla Costa
Journal:  Age (Dordr)       Date:  2010-07-14

2.  Erectile function is improved in aged rats by PnTx2-6, a toxin from Phoneutria nigriventer spider venom.

Authors:  Kenia P Nunes; Haroldo A Toque; Marcia H Borges; Michael Richardson; R Clinton Webb; Maria Elena de Lima
Journal:  J Sex Med       Date:  2012-08-23       Impact factor: 3.802

3.  Chronic oral administration of the arginase inhibitor 2(S)-amino-6-boronohexanoic acid (ABH) improves erectile function in aged rats.

Authors:  Robert Segal; Johanna L Hannan; Xiaopu Liu; Omer Kutlu; Arthur L Burnett; Hunter C Champion; Jae Hyung Kim; Jochen Steppan; Dan E Berkowitz; Trinity J Bivalacqua
Journal:  J Androl       Date:  2012-04-05

4.  Penile Hemodynamic Response to Phosphodiesterase Type V Inhibitors after Cavernosal Sparing Inflatable Penile Prosthesis Implantation: A Prospective Randomized Open-Blinded End-Point (PROBE) Study.

Authors:  Adham Zaazaa; Michaela Bayerle-Eder; Ramzy Elnabarawy; Mahmoud Elbitar; Taymour Mostafa
Journal:  Adv Urol       Date:  2021-06-28

5.  Postmicturition Dribble Is Associated with Erectile Dysfunction in Middle-Aged and Older Men with Lower Urinary Tract Symptoms.

Authors:  Dae Yul Yang; Kyungtae Ko; Seong Ho Lee; Jin Seon Cho; Sang Kon Lee; Tae Young Shin; Won Ki Lee
Journal:  World J Mens Health       Date:  2018-09       Impact factor: 5.400

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.